ADDITIONAL INFORMATION 21 21.1.5 OTHER SECURITIES GIVING ACCESS TO The BCE 2014-06 warrants may be exercised by the beneficiary SHARE CAPITAL on the basis of the following vesting schedule: As of the date of this Registration Document, the total number • up to 1/4 of the BCE 2014-06 warrants on the first anniversary of ordinary shares that can be issued by full exercise of all of the of the date of grant; securities giving access to the capital and instruments issued to • the remaining 75% becoming exercisable up to 1/36 per month date amounts to 2,801,676, or a maximum dilution of 11.56% on from the first anniversary of the date of grant; and the basis of the capital and voting rights existing to date and 10.36% • at the latest within 10 years from the date of grant. on the basis of the capital and the fully diluted voting rights. BCE 2015-06 warrants and BSA 2015-06 warrants 21.1.5.1 Warrants With the authorization of the General Meeting of Shareholders (a) Warrants granted by the Company on June 29, 2015, the Board of Directors issued 733,298 BCE We have granted share-based warrants in the form of share 2015-06 warrants, with an exercise price of €3.275 per share, warrants for founders (Bons de Souscription de Parts de Créateur and 121,000 BSA 2015-06 warrants, with an exercise price of d’Entreprise, or BCE), share warrants (Bons de Souscription €3.275 per share on July 8, 2015. d’Actions, or BSA) and Stock Options (Options de souscription et/ou The BCE 2015-06 and BSA 2015-06 warrants may be exercised d’achat d’actions, or SO), since July 8, 2013. by the beneficiary on the basis of the following vesting schedule: As of the date of this Registration Document, 697,636 share • up to 1/4 of the BCE 2015-06 and BSA 2015-06 warrants on warrants for founder (BCE) will give right to 697,636 ordinary the first anniversary of the date of grant; shares with nominal value of €0.025 at an average exercise price • the remaining 75% becoming exercisable up to 1/36 per month of €2.419 per share. from the first anniversary of the date of grant; and As of the date of this Registration Document, 737,040 share • at the latest within 10 years from the date of grant. warrants (BSA) will give right to 737,040 ordinary shares with nominal value of €0.025 at an exercise price of €3.408 per share. BSA 2016 warrants With the authorization of the General Meeting of Shareholders BCE 2013-02 warrants and BSA 2013-02 warrants on May 19, 2016, the Board of Directors ssued 205,000 BSAi With the authorization of the general meeting of shareholders 2016 warrants, with an exercise price of €8.08 per share on on February 5, 2013, the Board of Directors issued 892,000 July 26, 2016. BCE 2013-02 warrants with an exercise price of €0.025 per share, and 328,000 BSA 2013-02 warrants with an exercise price The BSA 2016 warrants may be exercised by the beneficiary on of €0.025 per share on July 8, 2013. the basis of the following vesting schedule: • 100% of the BSA 2016 warrants on the first anniversary of the With the authorization of the general meeting of shareholders on date of grant; February 5, 2013, the Board of Directors issued 193,800 BCE 2013-02 warrants, with an exercise price of €0.025 per share and • at the latest within 7 years from the date of grant. 33,000 BSA 2013-02 warrants, with an exercise price of €0.025 With the authorization of the General Meeting of Shareholders per share on April 9, 2014. on May 19, 2016, the Board of Directors issued 165,000 BSA The BCE 2013-02 and BSA 2013-02 warrants are exercisable on 2016 warrants, with an exercise price of €5.04 per share on the basis of the following vesting schedule: July 27, 2017. • up to 1/4 of the BCE 2013-02 and BSA 2013-02 warrants on The BSA 2016 warrants may be exercised by the beneficiary on the first anniversary of the date of grant; the basis of the following vesting schedule: • the remaining 75% becoming exercisable up to 1/36 per month • up to 1/4 of the BSA 2016 warrants on the first anniversary of from the first anniversary of the date of grant; and the date of grant; • at the latest within 10 years from the date of grant. • the remaining 75% becoming exercisable up to 1/36 per month from the first anniversary of the date of grant; and BCE 2014-06 warrants • at the latest within 7 years from the date of grant. With the authorization of the general meeting of shareholders on June 25, 2014, the Board of Directors issued 60,000 BCE See also Section 15.4.1, “History of Share Warrants for Founders 2014-06 warrants on December 3, 2014, with an exercise price (BCE)”, and Section 15.4.2, “History of Share Warrants (BSA)” of of €0.025 per share. this Registration Document. 218– GENSIGHT BIOLOGICS – 2017 Registration Document